Moreover, AFAP1-AS1 over-expression has been more prominent in patients with distant or lymph node metastasis, advanced clinical stage, and greater tumor burden (75). This evidence concerns the gene AFAP1 and metastatic malignant neoplasm in the lymph nodes.